modafinil has been researched along with phosphocreatine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrère, B; Guezennec, CY; Lagarde, D; Menu, JP; Pérès, M; Piérard, C; Satabin, P | 1 |
| Blezer, EL; Jongsma, MJ; Olivier, B; Philippens, IH; van Vliet, SA; van Vlieta, SA; Vanwersch, RA | 1 |
2 other study(ies) available for modafinil and phosphocreatine
| Article | Year |
|---|---|
Effects of a vigilance-enhancing drug, modafinil, on rat brain metabolism: a 2D COSY 1H-NMR study.
Topics: Animals; Aspartic Acid; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Cognition; Creatine; Glutamic Acid; Inositol; Magnetic Resonance Spectroscopy; Male; Modafinil; Phosphocreatine; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity | 1995 |
Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Benzhydryl Compounds; Biomarkers; Brain; Callithrix; Disease Models, Animal; Dopamine; Drug Administration Schedule; Immunohistochemistry; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Modafinil; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Phosphocreatine; Predictive Value of Tests; Reproducibility of Results; Substantia Nigra; Treatment Outcome; Tyrosine 3-Monooxygenase | 2008 |